Mark For: EVRA-CEL™ trademark registration is intended to cover the categories of pharmaceutical and therapeutic preparations for the treatment of patients with chronic diseases, namely, cancer, kidney disease, diabetes, cachexia, age related sarcopenia, protein-energy wasting, and multiple sclerosis; pharmaceutical and therapeutic preparations for the treatment of autoimmune diseases and disorders. [all]
Status
2022-01-29 UTC
LIVE APPLICATION Awaiting Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and has not yet been assigned to an examiner.
(Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use
No
Current Use
No
Intent To Use
Yes
Filed ITU
Yes
44D Filed
No
44E Current
No
66A Current
No
Current Basis
No
No Basis
No
Attorney Name
Jesse A. Salen
Attorney Docket Number
33PB-347344
Timeline
2022-01-25
Application Filed
2022-01-28
Location: NEW APPLICATION PROCESSING
2022-01-28
Status: Live/Pending
2022-01-28
Status: New application will be assigned to an examining attorney approximately 6 months after filing date.
JESSE A. SALEN SHEPPARD MULLIN RICHTER & HAMPTON LLP 12275 EL CAMINO REAL, SUITE 100 SAN DIEGO, CA 92130
Good, Services, and Codes
IC 005. US 005 006 018 044 046 051 052. G & S: pharmaceutical and therapeutic preparations for the treatment of patients with chronic diseases, namely, cancer, kidney disease, diabetes, cachexia, age related sarcopenia, protein-energy wasting, and multiple sclerosis; pharmaceutical and therapeutic preparations for the treatment of autoimmune diseases and disorders
International Codes:
5
U.S. Codes:
005,006,018,044,046,051,052
Type Code
Type
GS0051
pharmaceutical and therapeutic preparations for the treatment of patients with chronic diseases, namely, cancer, kidney disease, diabetes, cachexia, age related sarcopenia, protein-energy wasting, and multiple sclerosis; pharmaceutical and therapeutic preparations for the treatment of autoimmune diseases and disorders
Trademark Filing History
Description
Date
Proceeding Number
NEW APPLICATION ENTERED IN TRAM
2022-01-28
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
OneLook
Acronym Finder
Atara Biotherapeutics, Inc.
Application
| 